HIV Vaccine in the Works
A new observation of the relationship between the HIV virus and certain antibodies is very exciting news from the land down under.
50 Percent of Teenagers are Takers of Free HIV Testing
In an effort to pump up teenage HIV testing, The Bradley Hasbro Children's Research Center offered free or low-cost HIV testing to teenagers. Government agencies recommend yearly HIV testing for all people from 13-64. Most people simply do not get tested for HIV, though.
Major AIDS Breakthrough
Since the early 1980's, the mysterious sexually transmitted virus later known has AIDS has destroyed many lives, families and children.
FDA Approves New HIV Drug
On March 25, 2011, FDA approved VIRAMUNE XR ( nevirapine ), a 400 mg extended release tablet formulation. VIRAMUNE XR is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.
Banning HIV Organ Donation
Researchers from Johns Hopkins believe that a law banning HIV patients from donating their organs to living HIV-positive patients is outdated. If the ban were reversed, hundreds of HIV-positive patients who need an organ could get their transplant within months instead of years.
This Drug is Not for Preemies
The FDA has warned health care professionals that an antiretroviral drug used to treat HIV infection may lead to serious heart, kidney, and breathing problems in premature babies.
New, Improved! Now With Less Glycerin!
Scientists recently developed an anti-HIV gel designed to be applied to the vagina. Now, a reformulated version of the gel appears to be safe for use in the rectum.
Saving the Baby from Mommy's Sickness
A new study has identified a new drug regimen that may reduce the risk of spreading HIV from an infected mother to her infant.
The Damage Done from the Get-Go
Using mice, researchers have modeled how the human body reacts to the early stages of HIV infection. The study also reveals how the disease is related to nerve cell damage.
Abacavir Update: Yes It's Still Safe, For Now
The FDA updated the public about an ongoing safety review of abacavir and a possible increased risk of heart attack. Since the announcement there has been conflicting information on the potential increased risk of heart attack.